Stocks · Health care · Biological Products, (No Diagnostic Substances)

Neumora Therapeutics, Inc.

NMRA Clue Score21
United States Fiscal year ends December CIK 0001885522 Results filed 14 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Paul L Berns
17 Feb 2026
See Remarks
Sell
9,819
$3.51
$34.46K
Joshua Pinto
17 Feb 2026
President
Sell
5,967
$3.54
$21.09K
Daljit Singh Aurora
17 Feb 2026
See Remarks
Sell
6,165
$3.56
$21.92K

What was left out

Form 4 filings counted 101
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 12
Sales on a Rule 10b5-1 plan 16
Sales straight out of an exercise 13
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 97,521,043
History held since 18 Sep 2023